Peculiar Pre-Medical Apex Institute Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth 7.27%
- Ebitda -18.31%
- Net Worth -22.99%
- Total Assets -20.44%
About Peculiar Pre-Medical Apex Institute
Peculiar Pre-Medical Apex Institute Private Limited (PPAIPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 May 2014 and has a history of Ten years and eight months. Its registered office is in Allahabad, Uttar Pradesh, India.
The Company is engaged in the Education & Learing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jafar Ismail, Mahendra Gupta, and Janardan Tripathi serve as directors at the Company.
Company Details
- Location
Allahabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U80300UP2014PTC063987
- Company No.
063987
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 May 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Peculiar Pre-Medical Apex Institute?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jafar Ismail  | Director | 27-May-2014 | Current |
| Mahendra Gupta | Director | 27-May-2014 | Current |
| Janardan Tripathi | Director | 27-May-2014 | Current |
Financial Performance of Peculiar Pre-Medical Apex Institute.
Peculiar Pre-Medical Apex Institute Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 7.27% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Peculiar Pre-Medical Apex Institute?
In 2017, Peculiar Pre-Medical Apex Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Peculiar Pre-Medical Apex Institute?
Unlock and access historical data on people associated with Peculiar Pre-Medical Apex Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Peculiar Pre-Medical Apex Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Peculiar Pre-Medical Apex Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
